|
|
 |
| |
 |
 |
Home > About US >
Company Introduction |
| |
|
|
| |
| Objective
(Mission) |
| To reveal a
significant scientific research achievement
about cancer therapy; To bring light to the
cancer patients in Greater China; To become
one of the leading publicly-listed medical
product companies in Asia. |
  |
| Company
Introduction |
| To boost
the biological Cancer-Cure drug UKRAIN to
marketization and capitalization, the expenditures
of development at earlier stage and market
expanding were wholly capitalized on July
5, 2001. According to international authorization,
the market value of a new drug will reach
approximately 800 million USD. Human Life
Holding invested 43.88 million USD to establish
HUMAN LIFE SCIENCE HOLDING CORP. in the Cayman
Islands of UK and four operating subsidiaries
as the mainbody of marketization and capitalization
in Greater China on July 5, 2001. Corporate
and organizational structure are as following: |
 |
| Note: Company 1 (hereafter
the "Company") above shall act as
holding company, company 2 shall act as trading
and distributing company, while companies
3, 4 and 5 shall act as operating companies
and co-operating with local hospitals. |
| Organizational
Structure |
 |
|
|
|
|
 |
|
